RESUMEN
OBJECTIVE: To evaluate the feasibility and safety of home monitoring of chronic heart failure (CHF) patients using acoustic wireless communication with an implant directly measuring pulmonary artery (PA) pressures. DESIGN: The PAPIRUS (Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal) II trial was a prospective, multicentre phase I study. PATIENTS: 31 patients with CHF in New York Heart Association class III-IV. INTERVENTIONS: Implantation of a miniature device in the right pulmonary artery (PA) responding to ultrasonic signal that enables wireless recording of a complete PA pressure curve. MAIN OUTCOME MEASURES: The primary end points were rates of serious adverse device- or implantation-related events at 6 months. Secondary end points included accuracy of the measured PA pressure, functionality of the system and evaluation of pressure readings at different postures. RESULTS: The two safety end points were met with no serious adverse events related to the device or implantation. Pressure tracings at 6 months were almost identical to those obtained simultaneously by Millar catheter. Variations of PA diastolic pressure were observed in relation to posture (standing 6.4 (SD 3.4) mm Hg lower than supine, p<0.001). A total of 4627 home measurements were successfully performed by 23 patients using a simple-to-operate hand-held home-unit for daily measurements. The median compliance with daily monitoring was 86%. CONCLUSIONS: Meeting the prespecified safety objective of this study warrants a randomised trial to fully evaluate the potential of home monitoring by this miniature PA implant in guiding long-term management in CHF.
Asunto(s)
Monitoreo Ambulatorio de la Presión Arterial/instrumentación , Insuficiencia Cardíaca/fisiopatología , Arteria Pulmonar/fisiopatología , Telemetría/instrumentación , Anciano , Anciano de 80 o más Años , Presión Sanguínea/fisiología , Monitoreo Ambulatorio de la Presión Arterial/efectos adversos , Monitoreo Ambulatorio de la Presión Arterial/métodos , Diseño de Equipo , Estudios de Factibilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Postura/fisiología , Telemetría/efectos adversos , Telemetría/métodosRESUMEN
OBJECTIVE: To evaluate the frequency and characteristics of visual hallucinations (VH) in patients with giant cell arteritis (GCA) and to determine their relationship to other visual phenomena. METHODS: This prospective study included 31 consecutive patients with GCA. All were asked whether they had experienced recent visual phenomena. Patients with visual symptoms underwent a comprehensive ophthalmologic examination. When unusual visual phenomena were reported, patients were asked to describe their nature, duration, and frequency of occurrence. RESULTS: Visual symptoms occurred in 6 patients: permanent visual loss in 5 and amaurosis fugax in one. In 4 of the 5 patients with permanent visual loss, it was preceded by intermittent VH over a period of 1-10 days. Patients were aware of the unreal nature of the visions. Hallucinations disappeared within 2 weeks, but in one patient, recurred 6 months later in association with further visual deterioration. CONCLUSION: The occurrence of visual hallucinations in patients with GCA-associated visual loss is more common than previously appreciated. As hallucinations preceded permanent loss of vision, this phenomenon may serve as a harbinger of imminent visual loss.
Asunto(s)
Ceguera/epidemiología , Arteritis de Células Gigantes/epidemiología , Alucinaciones/epidemiología , Distribución por Edad , Anciano , Anciano de 80 o más Años , Ceguera/diagnóstico , Comorbilidad , Femenino , Arteritis de Células Gigantes/diagnóstico , Alucinaciones/diagnóstico , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Prospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Distribución por SexoRESUMEN
Acute myocardial infarction with normal coronary arteries is a relatively infrequent finding. This report describes a rare combination of an embolic event to a normal coronary artery, presumably originating from a left atrial thrombus. An anomalous origin of the infarct-related coronary artery presumably enabled preferential penetration of the clot into the artery. The infarction was further complicated by rupture of the left ventricular free wall.
Asunto(s)
Vasos Coronarios , Embolia/complicaciones , Rotura Cardíaca Posinfarto/complicaciones , Infarto del Miocardio/etiología , Anciano , Angiografía Coronaria/métodos , Vasos Coronarios/diagnóstico por imagen , Ecocardiografía/métodos , Embolia/diagnóstico por imagen , Rotura Cardíaca Posinfarto/diagnóstico por imagen , Humanos , Masculino , Infarto del Miocardio/diagnóstico por imagenRESUMEN
This report describes an unusual course of rupture of the left ventricular free wall, complicating acute myocardial infarction. Spontaneous sealing of the rupture site enabled close echocardiographic follow-up, during which we monitored the development of intramyocardial dissecting hematoma and, finally, development of a full tear in the left ventricular free wall, leading to the formation of a pseudoaneurysm. The pathophysiology, management, and diagnostic criteria of these processes are being revised.
Asunto(s)
Ecocardiografía , Rotura Cardíaca Posinfarto/complicaciones , Rotura Cardíaca Posinfarto/diagnóstico por imagen , Adulto , Aneurisma Falso/diagnóstico por imagen , Aneurisma Falso/etiología , Hematoma/diagnóstico por imagen , Hematoma/etiología , Humanos , MasculinoRESUMEN
BACKGROUND: Patients with diabetes mellitus (D) (both insulin-requiring D [IRD] and non-IRD) who undergo angioplasty have worse long-term outcome than do non-D patients. Few data are available in the literature that explain these findings. HYPOTHESIS: The study was undertaken to compare restenosis and progression of coronary disease after angioplasty in IRD patients, in non-IRD patients, and in non-D patients. METHODS: Diabetic patients who underwent coronary angioplasty were separated into two subgroups: IRD and non-IRD patients. Their angiographic outcome was compared with non-D patients. We examined retrospectively 353 coronary angiograms of patients who were referred for diagnostic angiography > 1 month after successful angioplasty. Quantitative angiography was used to determine the outcome in dilated narrowings (restenosis) and in nondilated narrowings (disease progression). RESULTS: Baseline clinical and angiographic characteristics were similar in all groups. Restenosis rate was higher in IRD (61%) than in non-IRD (36%) and non-D (35%) patients (p = 0.04). Late luminal loss after angioplasty was two times greater in IRD patients than in the other two groups (p = 0.01). Disease progression of nondilated narrowings was significantly more prominent in non-IRD than in non-D patients: Diameter stenoses were similar in the initial angiogram, but narrowings were significantly more severe (p = 0.02) in the final angiogram (70 +/- 27% and 60 +/- 33%, respectively). New narrowings were more common in non-IRD than in non-D patients: there was a 23% increase in the number of narrowings in the follow-up angiogram in non-IRD patients compared with only 12% in non-D patients (p < 0.003). These new narrowings were more common (p = 0.01) in angioplasty arteries (57 narrowings on 420 arteries--13.6%) than in nonangioplasty arteries (54 narrowings on 639 arteries--8.5%). CONCLUSION: Restenosis is more common in IRD patients and explains the high rate of adverse cardiac events within the first year after coronary intervention in these patients (mainly target lesion revascularization). Disease progression (including new narrowings) is the main determinant of patient outcome > 1 year after coronary intervention and is accelerated in non-IRD compared with non-D patients.
Asunto(s)
Angioplastia Coronaria con Balón , Enfermedad Coronaria/terapia , Angiopatías Diabéticas/terapia , Anciano , Angiografía Coronaria , Diabetes Mellitus Tipo 1/terapia , Diabetes Mellitus Tipo 2/terapia , Angiopatías Diabéticas/diagnóstico por imagen , Angiopatías Diabéticas/patología , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Recurrencia , Estudios RetrospectivosRESUMEN
PURPOSE: Myocardial perfusion imaging can be performed using SPECT or positron emission tomography (PET). SPECT has lower specificity than PET, largely as a result of attenuation artifacts; however, it is more widely available. The authors describe a study of the effect of sex and body weight on the incidence of SPECT attenuation artifacts using a retrospective comparison of TI-201 SPECT and Rb PET. METHODS: One hundred sixty-one persons (101 men, 60 women; 81 normal weight, 80 overweight) underwent TI-201 SPECT and Rb PET. The incidence of observed perfusion defects was studied in territories of the three major coronary arteries. SPECT and PET results were also compared with those of angiography in a subset of 75 patients. RESULTS: One hundred fourteen defects were reported on Rb PET compared with 176 defects with TI-201 SPECT. Excess TI-201 SPECT defects occurred in male and female, normal-weight and overweight persons. The average specificity was 64% for TI-201 SPECT and 84% for Rb PET, reflecting this difference. CONCLUSIONS: Attenuation artifacts in TI-201 SPECT occur frequently and are not confined to easily identifiable subgroups of patients. Therefore, measures to improve specificity of SPECT (e.g., prone or gated imaging) or alternative imaging techniques such as PET have potential advantages for everyone, not simply for obese patients and women with large breasts. In addition, awareness of the prevalence of SPECT attenuation artifacts, in both sexes and all weight categories, may contribute to improved accuracy of interpretation.
Asunto(s)
Artefactos , Enfermedad Coronaria/diagnóstico por imagen , Corazón/diagnóstico por imagen , Obesidad/complicaciones , Radioisótopos de Rubidio , Radioisótopos de Talio , Tomografía Computarizada de Emisión de Fotón Único , Tomografía Computarizada de Emisión , Peso Corporal , Femenino , Humanos , Incidencia , Masculino , Estudios Retrospectivos , Sensibilidad y Especificidad , Factores SexualesRESUMEN
AIMS: This multicentre randomized study set out to evaluate whether coronary stenting improves the results of successful balloon angioplasty for chronic total occlusion. Balloon angioplasty for chronic total occlusion has a high restenosis rate. Several reports have suggested that coronary stenting may decrease the likelihood of restenosis and reocclusion. METHODS AND RESULTS: Patients with total coronary artery occlusions who had an optimal PTCA result were randomized either to no further treatment or additional stent implantation. The AVE microstent was used and all patients were scheduled for a 1-, 3-, and 6-month clinical follow-up. Repeat coronary angiography to assess the rate and pattern of restenosis was performed at 6 months or earlier if clinically indicated. Ninety-six patients were enrolled in this study. The mean age was 59. 3+/-10.3 years and 15 were females. Forty-eight patients were randomized to the stent arm, receiving 52 stents (lengths 18-39 mm). Stent implantation was successful in all and there were no major procedure-related complications. Sixty-nine patients (72%) were restudied after 6 months. The binary restenosis rates (50%), in the PTCA arm were 70.9% with a minimal lumen diameter of 1.01+/-0.79 mm compared to 42.1% in the stent arm with a minimal lumen diameter of 1.63+/-1.02 mm (P=0.034). Reocclusion occurred in 7.9% in the stent group compared to 16.1% in the PTCA group. Restenosis in the PTCA group was focal in 88% of patients and occurred at the point of total obstruction (within 5 mm), compared to diffuse instent restenosis, which occurred in 54% of the patients in the stent group. CONCLUSION: Coronary stenting can significantly decrease the rate of restenosis and reocclusion of total occlusions. As restenosis in the stent group was more diffuse, care should be taken to implant short stents at the site of occlusion.
Asunto(s)
Angioplastia Coronaria con Balón , Enfermedad Coronaria/prevención & control , Enfermedad Coronaria/cirugía , Implantación de Prótesis , Stents , Enfermedad Crónica , Angiografía Coronaria , Femenino , Humanos , Israel , Masculino , Persona de Mediana Edad , Isquemia Miocárdica/prevención & control , Isquemia Miocárdica/cirugía , Estudios Prospectivos , Resultado del TratamientoRESUMEN
Deep sclerectomy (DS) can be used in glaucoma with increased intraocular pressure when medical treatment fails. It involves removing part of the ocular drainage apparatus. Resistance to intraocular fluid drainage is decreased, improving drainage and decreasing intraocular pressure. By avoiding anterior chamber penetration, DS diminishes frequency of the complications of filtering surgery. 24 eyes of 23 patients underwent DS for primary or secondary open angle glaucoma with elevated intraocular pressure not controlled medically. It included preparation of a 4.0 x 4.0 mm limbal-based external scleral flap, dissecting and removing most of an internal scleral flap (leaving it 1 mm smaller than the external flap), unroofing Schlemm's canal and removing fine endothelial tissue lining its inner walls. The external scleral flap was then repositioned and sutured. Collagen implants were not used. In some cases DS was combined with extracapsular cataract extraction and intraocular lens implantation. Mean intraocular pressure decreased from 24.8 +/- 3.9 mmHg initially to 12.8 +/- 4.4 mmHg 6 months after operation (p < 0.0001). There was no difference in postoperative intraocular pressure between DS as a single procedure or as part of a combined operation. Complications were mild and of short duration. If long-term follow-up shows that lowered intraocular pressures are maintained, DS should be a surgical option in earlier stages of glaucoma.
Asunto(s)
Glaucoma de Ángulo Abierto/cirugía , Esclerótica/cirugía , Extracción de Catarata , Colágeno , Femenino , Humanos , Implantación de Lentes Intraoculares , Masculino , Persona de Mediana Edad , Colgajos Quirúrgicos , Resultado del TratamientoRESUMEN
BACKGROUND: Myocardial infarction (MI) as the first indication of postangioplasty restenosis is extremely rare, and it has been speculated that the fibroproliferative restenotic lesion is less likely to undergo plaque rupture than the lipid-laden native atherosclerotic lesion. HYPOTHESIS: The present study was designed to examine whether intracoronary stent implantation affects this course. METHODS: In all, 994 consecutive patients who underwent angioplasty and intracoronary stent implantation in our hospital were reviewed retrospectively for the occurrence of MI. RESULTS: Eight patients (0.8%), all male and hypertensive, aged 33-83 years, presented with an MI due to stent occlusion more than 30 days following stenting (range: 35-398 days). In two patients, MI occurred 3 and 5 h, respectively, following completion of a maximal high-level exercise test that was negative for ischemia. Angiography revealed complete occlusion or significant stenosis of the stent in all eight patients, with an obvious intimal dissection in either edge of the stent in six patients. Except for gender and hypertension, no correlation was found with other risk factors, vessel involved, initial angiographic results, or with stent design, diameter, or length. CONCLUSIONS: Myocardial infarction as a late complication of successful stent implantation occurred in 0.8% of our patients. This is only the lower bound of the estimated frequency for such an event. We hypothesize that the transition point between the relatively fixed stent and the normal artery is exposed to high deformation stress which makes it vulnerable to rupture and dissection. Strenuous exercise and hypertension may increase the deformation stress and the risk of intimal rupture.
Asunto(s)
Angioplastia Coronaria con Balón/efectos adversos , Infarto del Miocardio/etiología , Stents/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Angioplastia Coronaria con Balón/métodos , Angiografía Coronaria , Enfermedad Coronaria/diagnóstico , Enfermedad Coronaria/terapia , Electrocardiografía , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico , Pronóstico , Estudios Retrospectivos , Medición de Riesgo , Índice de Severidad de la Enfermedad , Factores de TiempoRESUMEN
PURPOSE: To evaluate the efficacy and risks of complications of topical mitomycin C (MMC) for small-size conjunctival intraepithelial neoplasia (CIN). METHODS: Eight patients with clinically diagnosed CIN <8 mm were included in the study. Patients received topical drops of MMC, 0.02-0.04%, 4 times daily for 14 days. Retreatment was done when lesions were not eliminated or recurred after the first treatment. RESULTS: Three patients remained disease free after one course of MMC application. Retreatment was done in four patients because of lesions that decreased in size but were not eliminated, and for regrowth in one case. After retreatment, the lesions were eradicated in four patients, whereas in one patient, the treatment failed, and the lesion was surgically excised. The complications of MMC use included mild conjunctival hyperemia in two patients and mild allergy in one patient, which resolved after discontinuation of the treatment. CONCLUSION: Application of topical MMC is an effective treatment for most but not all cases of small-size CIN.
Asunto(s)
Antibióticos Antineoplásicos/uso terapéutico , Carcinoma in Situ/tratamiento farmacológico , Neoplasias de la Conjuntiva/tratamiento farmacológico , Mitomicina/uso terapéutico , Adulto , Anciano , Antibióticos Antineoplásicos/administración & dosificación , Carcinoma in Situ/patología , Neoplasias de la Conjuntiva/patología , Diagnóstico Diferencial , Femenino , Humanos , Leucoplasia/tratamiento farmacológico , Leucoplasia/patología , Masculino , Persona de Mediana Edad , Mitomicina/administración & dosificación , Soluciones Oftálmicas/administración & dosificación , Soluciones Oftálmicas/uso terapéuticoRESUMEN
OBJECTIVES: The study sought to determine the 6-month clinical outcome of patients who underwent implantation of very long coronary stents to treat diffuse disease and/or long dissections and to compare the findings with those reported in the literature for patients who underwent implantation of multiple short coronary stents. BACKGROUND: New designs of flexible stents enable the implantation of long stents rather than multiple short, older design stents. The initial experience is very promising but the long-term outcome has not been described yet. METHODS: Fifty-seven consecutive patients in whom 67 long stents (>/=30 mm) were successfully deployed were included in this study. Six-month clinical and angiographic follow-up was prospectively collected. Patients with recurrent angina underwent coronary angiography without further testing. Patients who remained asymptomatic at the 6-month follow-up visit underwent positron emission tomographic imaging, and those with results suggestive of ischemia underwent coronary angiography. A combined study end point was defined as death, myocardial infarction, and the need for target vessel revascularization. RESULTS: Only 1 patient (2%) reached a study end point at hospital discharge. An additional 20 patients (total 21 patients [37%]) reached an end point by 6 months. The outcome was not influenced by the clinical presentation (stable or unstable angina) or by the indication for stenting (elective or emergency). Predictors for adverse outcome were multiple stents per narrowing (63% vs 29%, P <. 04), and stents smaller than 3.5 mm (49% vs 22%). Narrowing and stent length were not predictive of a study end point in narrowings that were successfully treated by a single long stent. CONCLUSIONS: Elective stenting provides an effective solution for patients with diffuse coronary disease provided that a single long stent (usually <40 mm) can cover the full length of the narrowing. The results are better when vessels larger than 3 mm are treated. Compared with multiple short stents, implantation of a single long stent is probably at least as effective, and the procedure is quicker and cheaper and thus should be the preferred approach.
Asunto(s)
Angioplastia/instrumentación , Enfermedad Coronaria/cirugía , Evaluación de Resultado en la Atención de Salud , Stents , Anciano , Angioplastia/economía , Angioplastia/normas , Diseño de Equipo , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Myocardial bridge is a not uncommon finding in routine diagnostic coronary angiography or pathological examination of the heart. It is almost always confined to the left ventricle and the left anterior descending coronary artery. This report describes a patient with chronic lung disease, severe left ventricular dysfunction, and pulmonary hypertension in whom coronary angiography revealed bridging of the right ventricular branch of the right coronary artery.
Asunto(s)
Anomalías de los Vasos Coronarios/diagnóstico por imagen , Hipertensión Pulmonar/diagnóstico por imagen , Miocardio/patología , Anciano , Cateterismo Cardíaco , Angiografía Coronaria , Anomalías de los Vasos Coronarios/patología , Insuficiencia Cardíaca/complicaciones , Ventrículos Cardíacos/patología , Humanos , Hipertensión Pulmonar/patología , Enfermedades Pulmonares Obstructivas/complicaciones , Masculino , Disfunción Ventricular Izquierda/complicacionesRESUMEN
The Cordis CrossFlex trade mark stent is a balloon expandable helical coil made of stainless steel. OBJECTIVE: To assess the short- and long-term safety and efficacy of this stent by conducting a multi-center national registry. METHODS: One hundred and sixteen stents were implanted in 109 patients (mean age 59 3 10 years, 95 males). The lesions were classified as type B2 or C in 56 patients (51%). Successful deployment was achieved in 103 patients (94.5%). Failure was due to damage to the stent (two patients) or inability to reach the lesion (four patients). High-pressure deployment (>14 atm) was used in 68% of cases. RESULTS: Edge dissections occurred in nine patients after high-pressure deployment and necessitated implantation of a second stent. One patient with a large acute myocardial infarction died during hospitalization. Side branch occlusion occurred in five patients (4.6%). Subacute thrombosis occurred in two patients (1.8%) during the first four weeks. During a six-month follow-up period, 18 patients (16.5%) were rehospitalized with recurrent angina. Fifteen patients had coronary angiography and 13 (12.1%) needed additional target lesion revascularization (TLR). Twelve patients required a second PTCA for in-stent restenosis, and one needed a coronary artery bypass graft operation. CONCLUSIONS: The CrossFlex coronary stent can successfully be used in complex coronary lesions, with few short-term complications and a low TLR rate. Operators should be aware of the possibility of edge dissection during high-pressure implantation.
RESUMEN
The Cutting Balloon consists of a standard balloon dilatation catheter with four microtome-sharp blades that incise the plaque and minimize arterial wall trauma. It was used in 31 patients; nine had calcified arteries, ten had non-compliant lesions, three had in-stent restenosis and nine had aorto-ostial lesions. Seventeen lesions were predilated, 28 were post-dilated and 18 required stent implantation. The procedure was very effective in aorto-ostial lesions, non-compliant lesions that were not responsive to high-pressure balloon dilatation, and was partially successful in calcified arteries. It has a very specific niche in selected lesions.
RESUMEN
Coronary angiography is not sensitive enough to define the results of stent implantation. Intravascular ultrasound defines accurately the anatomy of the vessel and the stent within the vessel and is thus considered the gold standard for defining the results of stent implantation. However intravascular ultrasound is an additional invasive procedure that is time consuming and expensive. This study describes a new simple quantitative videodensitometric technique, developed specifically to assess the results of stent implantation and compares the findings to intravascular ultrasound. In the proposed algorithm for the videodensitometric analysis, density profiles were constructed perpendicular to the long axis of the stented segment and each one was compared (after background subtraction) with a theoretic profile of a normal artery at that location. Density deficit index was determined at each point from the actual and theoretic profiles and a global volumetric density deficit index was calculated for each stent by integrating the deficit indices at all points along the stent. Similarly an area stenosis was determined at each point along the stent (using the stent and normal vessel cross sectional areas as defined by intravascular ultrasound) and the global volumetric stent stenosis was calculated by integrating the values of area stenosis along the stent. Twenty-five patients were evaluated immediately before and after coronary stent implantation. Global density deficit index improved from 66.1+/-16.4% before (after last balloon inflation) to 44.4+/-11.1% after stenting (P < 0.001). The shape of the curves of densitometric deficit indices along each stent were similar to the equivalent area stenosis curves as determined by intravascular ultrasound. The correlation (R = 0.74) between the global volumetric density deficit index and the global volumetric stent stenosis is statistically significant (P < 0.001). In conclusion, in this preliminary report we describe a new algorithm for videodensitometric analysis of the results of coronary stent implantation. As compared with intravascular ultrasound this method does not require an additional invasive procedure and it is quick cheap and easy to carry out.
Asunto(s)
Algoritmos , Angiografía Coronaria , Endosonografía/métodos , Grabación en Video , Interpretación Estadística de Datos , Densitometría/métodos , Densitometría/estadística & datos numéricos , Endosonografía/normas , Humanos , Sensibilidad y Especificidad , Stents , Resultado del TratamientoRESUMEN
The long term impact of pre-hospital thrombolysis in acute myocardial infarction on the subsequent development of heart failure symptoms was investigated in 362 consecutive patients. The pre hospital strategy, used in 61 patients, allowed for very early administration of streptokinase, within 1.2+/-0.6 (mean+/-S.D.) hours from pain onset. In contrast, 294 patients treated in hospital received lytic treatment within 2.0+/-0.9 hours. The pre hospital group showed faster reperfusion, as measured by the time to peak creatine kinase and to ST segment recovery, but only a slightly better ventricular function, as compared to hospital treated patients. Heart failure symptoms were significantly reduced in the pre hospital group during hospitalization and at long term follow up: there were less dyspnea, fatigue, orthopnea, nocturnal dyspnea, nocturia, peripheral edema and episodes of pulmonary edema. Angina was reduced as well. We conclude that the initial benefit of prehospital thrombolysis translates into long term reduction of heart failure symptoms, thus improving quality of life.
Asunto(s)
Fibrinolíticos/uso terapéutico , Insuficiencia Cardíaca/prevención & control , Infarto del Miocardio/tratamiento farmacológico , Estreptoquinasa/uso terapéutico , Terapia Trombolítica , Femenino , Estudios de Seguimiento , Insuficiencia Cardíaca/etiología , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/complicaciones , Factores de TiempoRESUMEN
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu) disease is characterized by cutaneous, mucosal, and visceral vascular anomalies. Two patients were previously described with coronary artery aneurysms (ectasia) associated with this disease. This report describes a patient with Osler-Weber-Rendu disease in whom multiple coronary arteriovenous malformations were identified during coronary angiography. The patient presented with anginal chest pain resulting from severe anemia. Upper gastrointestinal endoscopy revealed multiple angiodysplastic lesions throughout the esophagus and stomach.
Asunto(s)
Malformaciones Arteriovenosas/complicaciones , Anomalías de los Vasos Coronarios/complicaciones , Telangiectasia Hemorrágica Hereditaria/complicaciones , Anemia Ferropénica/complicaciones , Anemia Ferropénica/terapia , Malformaciones Arteriovenosas/diagnóstico por imagen , Transfusión Sanguínea , Angiografía Coronaria , Anomalías de los Vasos Coronarios/diagnóstico por imagen , Endoscopía del Sistema Digestivo , Esófago/irrigación sanguínea , Estudios de Seguimiento , Hemorragia Gastrointestinal/complicaciones , Hemorragia Gastrointestinal/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Estómago/irrigación sanguínea , Telangiectasia Hemorrágica Hereditaria/diagnósticoRESUMEN
A small gap between stent struts is essential to support the vessel wall, prevent elastic recoil, and prevent intimal flaps from prolpasing into the lumen. We defined Gap Index as the ratio of strut width divided by the percent of the vessel wall area covered by the stent metal, and proved mathematically that this index relates inversely to the total length of stent struts (or coil), and directly related to stent cell size. Twenty-four (12 tubular and 12 coil) stents from 17 manufacturers were analyzed. Strut width in the tubular and coil groups was 354.1 +/- 276.0 and 955.9 +/- 553.9 microm, respectively (P < 0.001). The relative metallic surface area (RMS) in the tubular and coil groups for 3 mm stent diameter was 16.0 +/- 4.6 and 10.6 +/- 3.7%, respectively (P < 0.005). Great variations in Gap Index were found amongst different stents, with up to 100-fold. Gap Index in the tubular and coil groups for 3 mm stent diameter was 24.4 +/- 21.7 and 105.8 +/- 97.5 units, respectively (P = 0.001). Thus, coil stents have a smaller relative metallic surface area despite increased strut width. This is the result of reduced total strut length and fewer and larger cells, as represented by a higher Gap Index. This information may be useful for new stents designs.
Asunto(s)
Vasos Coronarios/cirugía , Modelos Estructurales , Stents/normas , Materiales Biocompatibles , Elasticidad , Metales , Modelos TeóricosRESUMEN
Coronary arteries in diabetic patients appear to be narrower than in normal subjects, but this has not been examined systematically. To investigate this hypothesis we reviewed the data of 711 consecutive patients with angiographically 'normal coronary arteries'. Excluded were patients with valvular, myocardial or pericardial disease, and patients with hypertension or hyperlipidemia. Thirteen diabetic patients (10 men) and 22 nondiabetic persons (8 men) constituted the study and control groups, respectively. The diameters of the coronary arteries and their branches were measured and adjusted for body surface area. The sum of the proximal left anterior descending (LAD), circumflex and right coronary arteries (RCA) was calculated and defined as total coronary diameter (TCD). The sum of the distal LAD, first diagonal, first marginal and distal RCA was calculated and defined as total distal coronary diameter (dTCD). The clinical data of both groups were comparable. Adjusted TCD for body surface area was 5.4 +/- 1.1 and 6.5 +/- 1.1 mm/m2 (p < 0.05) in diabetics and nondiabetics, respectively, and adjusted dTCD was 4.9 +/- 1.2 and 6.1 +/- 1.2 mm/m2 (p = 0.01) in diabetics and normal subjects, respectively. Specific arteries and branches that were significantly smaller in diabetics included: left main coronary artery, distal LAD, first diagonal, proximal RCA, distal RCA, right ventricular branch, and posterolateral and posterior descending artery of RCA origin. Gender was not a confounding factor since the control group had a larger proportion of women and still larger arteries than the diabetic group. In conclusion, coronary arteries and their branches in diabetic patients have smaller diameters than normal subjects. This may be due to increased coronary tone, diffuse mild atherosclerosis or both.
Asunto(s)
Angiografía Coronaria , Enfermedad Coronaria/diagnóstico por imagen , Angiopatías Diabéticas/diagnóstico por imagen , Enfermedad Coronaria/fisiopatología , Angiopatías Diabéticas/fisiopatología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Volumen SistólicoRESUMEN
The aim of our study was to define the appearance of methyl methacrylate grafts replacing resected sternum and ribs on CT and MRI and how the sternal graft may mimic an abnormally sclerotic sternum on CT images. We reviewed the CT scans of nine patients who had undergone chest wall resection (eight with malignant and one with benign disease) and reconstruction with a composite of methyl methacrylate and Marlex mesh graft. One of them had an MRI study as well. The size, shape and CT attenuation were assessed on mediastinal and bone window settings. The sternal graft was seen on mediastinal and even better on bone windows as an abnormally wide, irregularly shaped structure, somewhat denser than the normal sternum. The chest wall prosthesis replacing resected ribs was seen as a continuous dense structure and of similar attenuation as that of the sternal graft. On MRI the prosthesis appeared as a well-defined structure with no signal. Reconstruction of the chest wall with methyl methacrylate appears on CT as a diffusely dense sclerotic bone lesion not unlike a malignant lesion. The possibility of a graft has to be included in the differential diagnosis in these cases.